Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

As a huge market opens up before vaccine manufacturers, with the Centre allowing everyone above 18 years of age to take the life-saving jab, firms have geared up for expansion plans to ensure sufficient availability.

From Bharat Biotech and Serum Institute of India (SII)  to Zydus Cadila, all major vaccine makers are en route to expand their production capacity to make Covid-19 vaccines. 

Motilal Oswal says the latest government announcement to allow vaccinations for all can create an additional demand for 1.2 billion doses.

Raw material availability, however, will continue to plague some manufacturers, while others are securing raw material supplies locally.

While Bharat